Ganaxolone
Overview
Ganaxolone is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1568698).
API suppliers (1)
Suppliers of Ganaxolone evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.
1 of 1 holds a GMP certificate on record in the EU or UK registers
- CURIA SPAIN SAUSpain1 active DMF GMP on record
Patent & exclusivity (US)
Per the FDA Orange Book (1 approved US product), the latest listed US patent on Ganaxolone expires 30 Sept 2042 and exclusivity 1 Jun 2029. Generic API sourcing typically opens up once these lapse.
Chemical identity
- IUPAC name
- 1-[(3R,5S,8R,9S,10S,13S,14S,17S)-3-hydroxy-3,10,13-trimethyl-1,2,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl]ethanone
- Canonical SMILES
- CC(=O)[C@H]1CC[C@@H]2[C@@]1(CC[C@H]3[C@H]2CC[C@@H]4[C@@]3(CC[C@@](C4)(C)O)C)C
- InChIKey
- PGTVWKLGGCQMBR-FLBATMFCSA-N
Do you supply Ganaxolone? Get in front of buyers actively sourcing it.
We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.